CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.

Allogeneic hematopoietic cell transplantation (alloHCT) using tremtelectogene empogeditemcel (trem-cel), a CRISPR–Cas9–edited ...

ChristianaCare’s Gene Editing Institute has launched DECODR, Inc., a new for‑profit company created to expand access to one of the world’s leading software tools to evaluate the effectiveness of ...

Tuberculosis (TB) remains one of the leading causes of mortality from a single infectious agent worldwide and continues to pose a major public health ...

Experienced Life Sciences Patent Attorney Strengthens Firm’s IP Capabilities ATLANTA—(May 12, 2026)—FisherBroyles, LLP, the world’s first and one of the largest distributed law firms, is pleased to ...

UC Davis researchers engineered wheat that encourages soil bacteria to convert atmospheric nitrogen into plant-usable fertilizer. By boosting a natural compound in the plant, the wheat triggers ...

Cathie Wood's ARKK ETF features Tesla, AMD, Coinbase, and CRISPR Therapeutics as top holdings. Discover the fund's focus on ...

DNA synthesis technologies, supported by automated synthesizers, high-throughput platforms, oligonucleotide production ...

Live-cell breakthrough: Munich scientists created a method to repeatedly read genetic activity from living cells, enabling long-term study without cell destruction. CRISPR reimagined: Hong Kong ...

Historic same-day advances: Two major genetics breakthroughs were revealed: a vast blood protein genetics study and a DNA-guided CRISPR system for RNA targeting. Why it matters: The findings could ...

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...